RecruitingNot ApplicableNCT07298161
Evaluating SleepWhale Drops for Rest & Resilience
Sponsor
Efforia, Inc
Enrollment
100 participants
Start Date
Aug 25, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
30-day study evaluating SleepWhale Natural Sleep Drops (Extra Strength)-formulated to support deeper sleep and better days.
Eligibility
Inclusion Criteria3
- Can read and understand English.
- US resident.
- Willing and able to follow the requirements of the protocol.
Exclusion Criteria10
- Individuals with Allergies to supplement ingredients
- Individuals on sleep Medication
- Individuals with Gastrointestinal Issues
- Individuals with Skin Conditions
- Individuals Prone to Headaches
- Individuals with Mental Health Conditions
- Pregnant or Breastfeeding Individuals
- Athletes and Competitive Participants
- Individuals with Dependency Issues
- Individuals with Dizziness or Fatigue Issues
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIETARY_SUPPLEMENTSleepWhale Natural Sleep Drops
Broad spectrum hemp extract: 25 mg Broad spectrum hemp extract (CBN): 1.5 mg Proprietary blend of Suntheanine (L-Theanine), GadoMag (Magnesium( Sibelius (Camomile) and M2 (Lion's Mane)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07298161
Related Trials
GUTLINK4KIDS Intervention
NCT074012121 location
Impact of a Mandibular Oral Repositioning Device on Sleep Quality, Heart Rate Variability, & SpO2
NCT073596381 location
Evaluation of Cognitive Behavioral Therapy for Insomnia (CBT-I) in Individuals With Mild Traumatic Brain Injury (mTBI)
NCT073851051 location
Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty
NCT069022851 location
Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease
NCT059244251 location